Our study reveals how biomolecules TFF3, LCN2, CEACAM5, SELE, RETN, TFF1, and AHCY are involved in CRC progression through proteogenomic pathways such as PI3k/Akt, EGFR, PLC/PKC. This evidence concerns the gene HSPG2 and colorectal carcinoma.